Should You Short Las Vegas Sands Corp. (LVS) Now?

Page 1 of 2

Las Vegas Sands Corp. (NYSE:LVS) announced fourth quarter results after the bell last Wednesday. The stock, which was at $53.38 at opening trade on Jan. 28, slipped 3.9% to $51.05 at the close of trading the next day. On the day the results were to be released, the stock gained 0.94% and closed at $51.56. However, after the results became public, the after hours quote was $54.25, a gain of 5.22%.

Considering that the company reported an increase of 36% in fourth quarter profit and that the stock rose 15% in January, is LVS a buy at this price or is it a good short? Let us review the results and try to find an answer.

Las Vegas Sands Corp. (NYSE:LVS)Las Vegas Sands: The Company

LVS is a Fortune 500 company and a leading developer of destination properties (integrated resorts). It operates in Macao, Singapore and the US. The integrated resorts developed and operated by the company feature gaming, entertainment and retail, premium accommodations, convention and exhibition facilities. In Macao, the company operates through Sands China Ltd (SCL), 70.3% of which is owned by LVS. SCL operates The Venetian Macao; Four Seasons Macao; Sands Macao, and Other Asia (comprised primarily of its ferry operations and various other operations that are ancillary to its properties in Macao). The Singapore operating segment is comprised of Marina Bay Sands, which features roughly 2,600 rooms and suites along with 160,000 square feet of gaming space housing 2,500 slot machines and 600 gaming tables.

Las Vegas Sands’ US properties include the Venetian Resort Hotel Casino (The Venetian Las Vegas) and the Palazzo Resort Hotel Casino (The Palazzo), Five-Diamond luxury resorts on the Las Vegas Strip, as well as the Sands Expo and Convention Center (the Sands Expo Center) in Las Vegas, Nevada and the Sands Casino Resort Bethlehem (the Sands Bethlehem) in Bethlehem, Pennsylvania.

Earnings

  • Quarterly Results

Quarterly EPS of LVS declined sharply in the second quarter 2012 when it reported EPS of $0.44 as compared to $0.70 in the first quarter. However, in subsequent quarters, it was able to recover part of lost ground and reported EPS of $0.54 in the fourth quarter of 2012.

Net revenue increased by 20.9% and net income attributable to common stock rose by 35.8%, reaching $434.8 million. On Dec. 6 the company paid a special dividend of $2.75 per share in addition to the recurring dividend of $0.25 per share on Dec. 18.

Gaming volumes in Macao reached a record $622.2 million, which resulted in a 43.3% increase in property adjusted EBITDA in Macao.

  • Annual Results for the year ended Dec. 31, 2012

Net revenue for the year showed an increase of 18.3%, up from $9.41 billion to $11.13 billion. The company was able to post a record consolidated EBITDA of $3.79 billion, and net income attributable to common stock rose 20.1% to reach $1.52 billion or $1.85 per share. During the year, the company distributed $3.75 per share to shareholders by way of quarterly and special dividends.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!